Northern Trust
INAB icon

Northern Trust’s IN8bio INAB Stock Holding History

Northern Trust’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.3K Buy
20,440
+3,040
+17% +$5.88K ﹤0.01% 4303
2025
Q4 		$40.7K Buy
+17,400
New +$33.1K ﹤0.01% 4321
2025
Q2 		– Sell
-3,114
Closed -$15.5K – 4451
2025
Q1 		$15.5K Hold
3,114
– – ﹤0.01% 4362
2024
Q4 		$24K Buy
3,114
+2,114
+211% +$18.6K ﹤0.01% 4360
2024
Q3 		$8.1K Sell
1,000
-1,538
-61% -$27.9K ﹤0.01% 4390
2024
Q2 		$64.5K Buy
2,538
+904
+55% +$29K ﹤0.01% 4160
2024
Q1 		$57.8K Hold
1,634
– – ﹤0.01% 4202
2023
Q4 		$67.6K Buy
1,634
+192
+13% +$6.14K ﹤0.01% 4182
2023
Q3 		$45K Hold
1,442
– – ﹤0.01% 4193
2023
Q2 		$66.6K Buy
1,442
+1,000
+226% +$62.5K ﹤0.01% 4144
2023
Q1 		$17.2K Hold
442
– – ﹤0.01% 4473
2022
Q4 		$30.6K Buy
+442
New +$24.7K ﹤0.01% 4399

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Northern Trust's INAB Position: Q1 2026 in Review

Northern Trust increased its IN8bio (INAB) stake by 17% in Q1 2026, buying an estimated $5.88K and bringing the position to 20,440 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4303.

Northern Trust first reported a position in INAB in Q4 2022 and has held it in 12 quarters since. The position peaked at $67.6K in Q4 2023. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Northern Trust held 20,440 shares of IN8bio worth $30.3K as of Q1 2026.
  • Northern Trust bought 3,040 IN8bio shares in Q1 2026, an estimated $5.88K.
  • IN8bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4303 holding.
  • Northern Trust first reported a position in IN8bio in Q4 2022 and has held it in 12 quarters since.
  • Northern Trust's IN8bio position peaked at $67.6K in Q4 2023.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.